At Cytiva, we envision a world in which access to life-changing therapies transforms human health. With a rich heritage dating back hundreds of years, our wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, we bring an innovative mindset to our collaborations with customers to help them improve patient outcomes.
Life at Cytiva
Personalized and novel therapies are changing the treatment landscape at a rapid pace. With 6 of the 7 approved CAR T cell therapies including Cytiva solutions, we are helping our customers adapt to industry trends and bring these therapeutics to market.